Medical devices containing dry spun non-wovens of poly-4-hydroxybutyrate and copolymers

Patent metadata

Field	Value
Publication number	US-10227718-B2
Application number	US-201113160942-A
Country	US
Kind code	B2
Filing date	Jun 15, 2011
Priority date	Jun 15, 2010
Publication date	Mar 12, 2019
Grant date	Mar 12, 2019

Abstract

Continuous processing methods for making absorbable polymeric dry spun non-wovens with one or more of the following properties: high burst strength, fine fibers of average diameter from 0.01 μm to 50 μm, and thickness from 10 μm to 10 mm, have been developed. Improved fiber cohesion is made possible by controlling the tackiness of the fibers of the non-woven during web collection. The polymer is preferably a polyhydroxyalkanoate, more preferably, a 4-hydroxybutyrate polymer or copolymer. A non-woven of poly-4-hydroxybutyrate is most preferred. The non-wovens have fine fibers with average diameters ranging from 0.01 μm to 50 μm, and are derived by dry spun processing, during which a solution of polymer(s) is injected into a stream of high velocity air with a pressure of 1 to 500 psi for solvent stripping and polymer strand attenuation. The non-wovens can be used for a variety of purposes including fabrication of medical devices.

First claim

We claim:

1. A non-woven comprising poly-4-hydroxybutyrate (P4HB) or copolymer thereof, wherein the non-woven comprises fine fibers having an average diameter of from about 0.01 μm to about 50 μm, and a burst strength greater than 0.001 Kgf, wherein the non-woven is prepared by dry spinning P4HB or a copolymer thereof under conditions decreasing the initial weight average molecular weight of the P4HB or copolymer thereof less than 20% and wherein when the non-woven has an areal density of about 13.3 g/m 3 , the non-woven has a burst of strength of about 0.75 Kgf as determined by the ASTM D6797-02 Standard Test Method for Burst Strength.

2. The non-woven of claim 1 wherein the weight average molecular weight of the P4HB or copolymer thereof decreases less than 20% during the processing of the polymer or copolymer into the dry spun non-woven.

3. The non-woven of claim 1 wherein the P4HB or copolymer thereof has a weight average molecular weight greater than 50 kDa relative to polystyrene.

4. The non-woven of claim 1 wherein the P4HB or copolymer thereof has a weight average molecular weight greater than 210 kDa relative to polystyrene.

5. The non-woven of claim 1 wherein the P4HB or copolymer thereof is dissolved in a volatile solvent, and injected into a stream of accelerated gas at 1 to 500 psi (6.9 to 3,447 kPa) to form polymer strands, and the polymer strands are attenuated by the high velocity gas.

6. The non-woven of claim 1 formed into a device.

7. The device of claim 6 wherein the device is used for the repair, regeneration or replacement of soft tissue.

8. The device of claim 6 selected from the group consisting of a stent, stent graft, stent coating, drug delivery device, device for temporary wound or tissue support, repair patch, tissue engineering scaffold, retention membrane, anti-adhesion membrane, tissue separation membrane, hernia repair device, device coating, cardiovascular patch, catheter balloon, vascular closure device, sling, biocompatible coating, rotator cuff repair device, meniscus repair device, adhesion barrier, guided tissue repair/regeneration device, articular cartilage repair device, nerve guide, tendon repair device, intracardiac septal defect repair device, atrial septal defect repair device, PFO (patent foramen ovale) closure device, left atrial appendage (LAA) closure device, pericardial patch, bulking agent, filling agent, vein valve, heart valve, bone marrow scaffold, meniscus regeneration device, ligament and tendon graft, ocular cell implant, spinal fusion device, imaging device, skin substitute, dural substitute, bone graft substitute, wound dressing, and hemostat.

9. The non-woven of claim 1 further comprising a second polymer selected from the group consisting of a polymer of glycolic acid, lactic acid, 1,4-dioxanone, trimethylene carbonate, caprolactone and combinations thereof.

10. The non-woven of claim 1 further comprising additives selected from the group consisting of prophylactic agents; diagnostic agents; therapeutic agents; other polymers; proteins; growth factors; plasticizers; nucleants; compatibilizers; porogens; radiolabelled substances; imaging agents; radiopaque markers; contrast agents; anti-oxidants; dyes; viscosity modifiers; and odor control agents.

11. The device of claim 6 , wherein the non-woven is dry spun from the liquid resin mixture directly onto a scaffold or other substrate to form the device.

12. A method of using a device formed of a non-woven of P4HB or copolymer thereof, wherein the non-woven comprises fine fibers having an average diameter of from about 0.01 μm to about 50 μm, and a burst strength greater than 0.001 Kgf, wherein the non-woven is prepared by dry spinning of the polymer under conditions decreasing the initial weight average molecular weight of the P4HB or copolymer thereof less than 20%, and the extruded polymer strands are attenuated by high velocity air to form the non-woven and wherein when the non-woven has an areal density of about 13.3 g/m 3 , the non-woven has a burst of strength of about 0.75 Kgf as determined by the ASTM D6797-02 Standard Test Method for Burst Strength,
comprising inserting or implanting the device into an individual in need thereof.

13. The method of claim 12 wherein the device is selected from the group consisting of a stent, stent graft, stent coating, drug delivery device, device for temporary wound or tissue support, repair patch, tissue engineering scaffold, retention membrane, anti-adhesion membrane, tissue separation membrane, hernia repair device, device coating, cardiovascular patch, catheter balloon, vascular closure device, sling, biocompatible coating, rotator cuff repair device, meniscus repair device, adhesion barrier, guided tissue repair/regeneration device, articular cartilage repair device, nerve guide, tendon repair device, intracardiac septal defect repair device, left atrial appendage (LAA) closure device, pericardial patch, bulking and filling agent, vein valve, heart valve, bone marrow scaffold, meniscus regeneration device, ligament and tendon graft, ocular cell implant, spinal fusion device, imaging device, skin substitute, dural substitute, bone graft substitute, wound dressing, and hemostat.

14. The method of claim 12 wherein the fibers initially remain tacky during web collection, and subsequently fuse at their crossover points.

15. A method of making a medical device comprising dry spun non-woven of P4HB or copolymer thereof,
wherein the non-woven comprises fine fibers having an average diameter of from about 0.01 μm to about 50 μm, and a burst strength greater than 0.001 Kgf, wherein the non-woven is prepared by dry spinning P4HB or a copolymer thereof under conditions decreasing the initial weight average molecular weight of the P4HB or copolymer thereof less than 20% and wherein when the non-woven has an areal density of about 13.3 g/m 3 , the non-woven has a burst of strength of about 0.75 Kgf as determined by the ASTM D6797-02 Standard Test Method for Burst Strength, the method comprising forming the non-woven into the device.

Assignees

• Cahil Ryan
• Guo Kai
• Martin David P
• Rizk Said
• Ho Kicherl
• Williams Simon F
• Tepha Inc

Inventors

• Cahil Ryan
• Guo Kai
• Martin David P
• Rizk Said
• Ho Kicherl
• Williams Simon F

Classifications

• A61L2300/00

  Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices · CPC title

• A61L31/06

  obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds {(A61L31/041 takes precedence)} · CPC title

• Y10T442/608

  Including strand or fiber material which is of specific structural definition · CPC title

• D04H1/56

  in association with fibre formation, e.g. immediately following extrusion of staple fibres · CPC title

• A61L27/18 Primary

  obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds · CPC title